{"filings":[{"id":98496,"accession_number":"0000721371-26-000017","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q3 revenue +11% to $60.9B, non-GAAP EPS $3.17 (+35%), raises FY26 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Non-GAAP EPS $3.17, up 35% YoY; GAAP EPS $1.69, down 20% on $184M goodwill impairment in Navista & ION.","Revenue $60.9B, +11%; Pharmaceutical & Specialty segment profit +18% to $784M.","FY26 non-GAAP EPS guidance raised to $10.70-$10.80; adjusted free cash flow raised to $3.3B-$3.7B.","Global Medical segment profit fell 36% to $25M due to tariff impact; Other segment profit up 34% to $179M.","Completed $250M accelerated share repurchase; YTD buybacks $1.0B; leverage ratio lowered to 3.0X."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114008,"accession_number":"0000721371-26-000013","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2026-03-23T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health appoints Patricia Hemingway Hall as Board Chair; Kenny retires","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Gregory B. Kenny retired as Board Chair and director effective March 20, 2026; no disagreement with company.","Patricia A. Hemingway Hall appointed as Board Chair; former CEO of Health Care Service Corporation.","Company to release Q3 fiscal 2026 earnings on April 30, 2026; reaffirms confidence in fiscal 2026 outlook."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114007,"accession_number":"0000721371-26-000010","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2026-03-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Cardinal Health CAO Mary Scherer to retire in Feb 2027; search launched","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mary Scherer, SVP and Chief Accounting Officer, notified Cardinal Health of retirement effective February 2027.","Company will initiate a search for a successor; Scherer will remain CAO until replacement is onboarded.","Transition is planned with nearly one-year notice, ensuring orderly handoff."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114006,"accession_number":"0000721371-26-000004","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q2 revenue $65.6B (+19%), non-GAAP EPS $2.63 (+36%), raises FY26 EPS outlook to $10.15-$10.35","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $65.6B (+19% YoY); GAAP diluted EPS $1.97 (+19%); non-GAAP diluted EPS $2.63 (+36%).","Pharma & Specialty profit $687M (+29%); Global Medical Products profit $37M (+106%); Other profit $179M (+52%).","FY2026 non-GAAP EPS guidance raised to $10.15-$10.35, representing 23%-26% growth.","Year-to-date share repurchases of $750M completed; reached targeted leverage range.","Acquired Solaris Health (urology MSO, >750 providers) on Nov 3; introduced ContinuCare Pathway program."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":129636000000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114005,"accession_number":"0000721371-26-000003","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardinal Health raises FY2026 non-GAAP EPS outlook to at least $10.00, up from $9.65-$9.85","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Raises FY2026 non-GAAP diluted EPS guidance to at least $10.00 from prior range of $9.65-$9.85.","Specialty revenues expected to exceed $50B in FY2026, a 16% CAGR over three years.","Successfully transitioned distribution agreements for all drugs affected by 2026 Medicare Drug Price Negotiation Program.","Launched ContinuCare Pathway program; Publix enrolled ~1,400 pharmacies, expanding to over 11,000 retail and grocery pharmacies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130410,"accession_number":"0000721371-25-000133","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cardinal Health shareholders elect 12 directors, approve say-on-pay, ratify auditor at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All 12 director nominees elected with >95% support; broker non-votes 21.1M for each.","Non-binding advisory say-on-pay approved: 168.4M for (89.9%), 17.3M against.","Ratification of Ernst & Young as FY2026 auditor approved: 195.7M for, 12.3M against, zero broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130409,"accession_number":"0000721371-25-000128","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q1 revenue $64B (+22%), non-GAAP EPS $2.55 (+36%); raises FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $64B (+22% YoY); GAAP diluted EPS $1.88 (+11%); non-GAAP diluted EPS $2.55 (+36%).","Segment profit growth across all five segments; Pharmaceutical & Specialty profit up 26% to $667M.","FY2026 non-GAAP EPS guidance raised to $9.65-$9.85 (from $9.30-$9.50); adjusted free cash flow raised to $3.0-$3.5B.","Acquisition of Solaris Health expected to close early November; initiated $375M accelerated share repurchase in Q1."],"consensus_eps_estimate":null,"consensus_eps_actual":1.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":64009000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130408,"accession_number":"0000721371-25-000125","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-10-10T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cardinal Health enters $1B 364-day revolving credit facility expiring Oct 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Credit agreement dated October 7, 2025 replaces prior 364-day facility from Oct 2024.","Aggregate commitment of $1.0 billion; termination date October 6, 2026.","Outstanding loans may be converted to term loans due one year after termination date.","Financial covenant: Consolidated Net Leverage Ratio no greater than 3.75 to 1.00.","Facility supports general corporate purposes and backs commercial paper program."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130407,"accession_number":"0000721371-25-000122","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-10-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Cardinal Health extends receivables purchase facility term to September 2028","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["First Amendment to Fifth Amended and Restated Receivables Purchase Agreement dated Sept 30, 2025.","Facility term extended to September 28, 2028; no change in facility size disclosed.","Parties include subsidiaries Cardinal Health Funding, Griffin Capital, CH-23 Funding, and banks Wells Fargo, BNS, PNC, BofA, MUFG.","Amendment also includes a new Amended and Restated Fee Letter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146954,"accession_number":"0001193125-25-189845","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Cardinal Health issues $1B in notes to partially fund Solaris Health acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $600M of 4.500% notes due 2030 and $400M of 5.150% notes due 2035.","Net proceeds will fund a portion of the consideration for the proposed acquisition of Solaris Health.","Special mandatory redemption at 101% if acquisition not completed by Aug 12, 2026, or if abandoned.","Proceeds not escrowed; may be used for general corporate purposes pending acquisition close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146953,"accession_number":"0001193125-25-180900","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cardinal Health issues $1B notes: $600M at 4.500% due 2030, $400M at 5.150% due 2035","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $600M aggregate principal of 4.500% Notes due 2030 and $400M of 5.150% Notes due 2035.","Underwriters include Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC.","Offering made under effective shelf registration statement S-3ASR (333-289513).","Net proceeds not specified; debt issuance for general corporate purposes typical for such offerings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":146952,"accession_number":"0000721371-25-000075","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-08-12T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q4 non-GAAP EPS $2.08 (+13%); raises FY26 guidance; acquires Solaris Health for ~$1.9B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $60.2B flat YoY (+21% excluding contract expiration); non-GAAP EPS $2.08 (up 13%).","FY2025 non-GAAP EPS $8.24 (+9%); adjusted free cash flow $2.5B.","FY2026 non-GAAP EPS guidance raised to $9.30-$9.50 (from $9.10-$9.30).","Enters agreement to acquire Solaris Health (urology MSO, >750 providers) for ~$1.9B cash; expected close by end of CY2025.","Acquisition slightly accretive to non-GAAP EPS in first 12 months; Cardinal will own ~75% of The Specialty Alliance post-close."],"consensus_eps_estimate":null,"consensus_eps_actual":6.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":222578000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165451,"accession_number":"0000721371-25-000053","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardinal Health raises FY25 EPS guidance to $8.15-$8.20; sets FY26 preliminary EPS $9.10-$9.30","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Raising FY25 non-GAAP diluted EPS to $8.15-$8.20 (from $8.05-$8.15); 9% growth at midpoint.","Preliminary FY26 non-GAAP diluted EPS $9.10-$9.30 (+13% growth); adjusted FCF $2.75B-$3.25B.","Long-term FY26-FY28: 12-14% EPS CAGR; at least $10B total adjusted FCF; buybacks raised to $750M/year.","Launched The Specialty Alliance (GI Alliance, Urology Alliance); expanding Biopharma Solutions; new distribution center planned.","GMPD long-term target: $50M+ profit growth/year after FY26; FY25 GMPD profit narrowed to ~$130M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165450,"accession_number":"0000721371-25-000036","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q3 non-GAAP EPS $2.35, up 13% YoY; raises FY25 EPS guidance to $8.05-$8.15","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $54.9B flat YoY; up 19% ex-customer contract expiration.","GAAP diluted EPS $2.10; non-GAAP $2.35, up 13% on 21% non-GAAP op earnings growth.","Pharma & Specialty segment profit $662M (+14%); Medical segment profit $39M (+77%).","FY25 non-GAAP EPS guidance raised to $8.05-$8.15 from $7.85-$8.00.","Completed acquisition of Advanced Diabetes Supply Group on Apr 1; $375M ASR program executed."],"consensus_eps_estimate":2.2011,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":162419000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183101,"accession_number":"0000721371-25-000020","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health adds two independent directors: Musslewhite (ex-Definitive Healthcare) and Ramakrishna (SolarWinds CEO)","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert Musslewhite, former CEO of Definitive Healthcare, elected to board effective March 7, 2025.","Sudhakar Ramakrishna, President and CEO of SolarWinds Corporation, also elected as independent director.","Musslewhite will serve on Audit and Human Resources & Compensation Committees.","Ramakrishna will serve on Audit and Risk Oversight Committees.","Both directors are deemed independent under NYSE rules; no material transactions disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183100,"accession_number":"0000721371-25-000009","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q2 non-GAAP EPS $1.93 (+2% YoY); guides FY25 $7.85-8.00, closes GI Alliance deal","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $55.3B (-4% YoY; +16% ex-large customer expiration); GAAP EPS $1.65, non-GAAP EPS $1.93.","Pharm & Specialty segment profit $531M (+7%); Global Medical Products profit $18M vs $11M.","FY2025 non-GAAP EPS guidance raised to $7.85-$8.00 from $7.75-$7.90; segment profit growth revised.","Completed acquisition of 73% of GI Alliance (gastroenterology MSO) and ION acquisition in Dec.","Started commercial-scale production of actinium-225 for theranostics; new distribution center underway."],"consensus_eps_estimate":2.0582,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":107541000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183099,"accession_number":"0000721371-25-000003","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2025-01-14T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Cardinal Health raises FY2025 non-GAAP EPS guidance to high end of $7.75-$7.90 range","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Now expects FY2025 non-GAAP EPS toward high end of $7.75 to $7.90, driven by Pharmaceutical & Specialty Solutions strength.","Previous guidance range was $7.75-$7.90; update reflects improved segment performance.","Presenting at JP Morgan 43rd Annual Healthcare Conference on January 14, 2025.","Further details on FY2025 expectations to be provided on Q2 earnings call January 30, 2025."],"consensus_eps_estimate":2.0582,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":107541000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199687,"accession_number":"0000721371-24-000169","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-12-09T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Cardinal Health enters $1.0B term loan for acquisitions of GI Alliance and Advanced Diabetes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.0B aggregate term loan facility to pay cash consideration and transaction costs for pending acquisitions of GI Alliance (majority equity) and Advanced Diabetes Supply Group.","Commitment termination date is earlier of both acquisitions close without funding, both termination dates occur, or November 10, 2025.","Loans mature 3 years after borrowing; interest based on Term SOFR plus Applicable Margin tied to credit ratings.","Financial covenant requires Consolidated Net Leverage Ratio no greater than 3.75:1.0.","Customary representations, affirmative/negative covenants (liens, subsidiary debt), and events of default included."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199686,"accession_number":"0001193125-24-264393","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-11-22T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Cardinal Health Issues $2.9B in Senior Notes to Fund Acquisitions of GI Alliance and Advanced Diabetes Supply","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $500M of 4.700% Notes due 2026, $750M of 5.000% Notes due 2029, $1B of 5.350% Notes due 2034, and $650M of 5.750% Notes due 2054.","Net proceeds will partially fund the proposed acquisitions of GI Alliance Holdings and Advanced Diabetes Supply Group.","If the GI Alliance acquisition is not closed by November 11, 2025, the company must redeem the notes at 101% of principal plus accrued interest.","Bridge loan commitments from Bank of America were reduced by net proceeds and remaining excess commitments terminated on November 22, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199685,"accession_number":"0001193125-24-260394","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Cardinal Health prices $2.9B multi-tranche senior notes offering (2026-2054)","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $500M of 4.700% notes due 2026, $750M of 5.000% notes due 2029, $1,000M of 5.350% notes due 2034, and $650M of 5.750% notes due 2054.","Underwriters include BofA Securities, J.P. Morgan Securities, and Wells Fargo Securities.","Offering made under effective shelf registration statement (Form S-3).","Total aggregate principal amount of $2.9 billion across four tranches."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199684,"accession_number":"0001193125-24-255062","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"Cardinal Health acquires 71% of GI Alliance for ~$2.8B and ADSG for ~$1.1B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquires 71% stake in GI Alliance (gastroenterology MSO) for ~$2.8B cash; remaining ~29% callable at fair value after 3 years.","Acquires Advanced Diabetes Supply Group for ~$1.1B cash to merge with at-Home Solutions segment.","Both deals expected to close early CY2025 and be accretive to revenue, segment profit, and non-GAAP EPS in first 12 months.","Bridge loan facility of up to $2.9B from Bank of America to fund acquisitions; company plans to delever over 18-24 months.","FY2025 share repurchase plans unchanged; Investor Day scheduled for June 12, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199683,"accession_number":"0000721371-24-000132","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Cardinal Health shareholders elect 10 directors and approve say-on-pay at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders elected all 10 nominees to Board of Directors, including Robert W. Azelby and Michelle M. Brennan, with over 192 million votes for each.","Advisory vote on executive compensation (say-on-pay) approved with 172,738,569 votes for, 19,964,307 against.","Ratification of Ernst & Young LLP as independent auditor for fiscal 2025 approved with 202,732,608 votes for.","Shareholder proposal to prohibit re-nomination of directors failing majority vote was not approved, with 155,556,799 votes against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199682,"accession_number":"0000721371-24-000119","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-11-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q1 GAAP EPS $1.70; Non-GAAP EPS $1.88, up 9% YoY; Raises FY25 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $52.3B, down 4% (up 15% ex-large customer expiration); Pharmaceutical segment profit up 16% to $530M.","Non-GAAP operating earnings $625M (+12%) driven by brand/specialty growth and early COVID vaccine distribution.","Non-GAAP diluted EPS guidance raised to $7.75-$7.90 from $7.55-$7.70; adjusted free cash flow outlook now $1.0B-$1.5B.","Announced $1.1B cash acquisition of Integrated Oncology Network, adding 100+ providers across 10 states.","Completed $375M accelerated share repurchase in October; Global Medical Products segment profit fell to $8M from $12M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":52277000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199681,"accession_number":"0000721371-24-000112","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-10-10T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Cardinal Health enters $1.0B 364-day credit facility, ups commercial paper program to $3.0B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.0B revolving credit facility matures Oct 7, 2025, with optional term-out conversion.","Commercial paper program max increased from $2.0B to $3.0B via Fourth Amendment.","Covenant requires Consolidated Net Leverage Ratio <= 3.75x at each fiscal quarter end.","Interest based on Term SOFR plus margin based on credit rating; facility fee on total commitment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215702,"accession_number":"0000721371-24-000092","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-09-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Two Cardinal Health directors not standing for re-election at 2024 annual meeting","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Steven K. Barg and Sujatha Chandrasekaran informed company Sept 6 and 8 they will not stand for re-election.","Both have served since 2022 under cooperation agreement with Elliott; decisions not due to any disagreement.","They will continue as directors until 2024 annual meeting; Barg served on Business Review Committee which sunsetted July 15.","Chandrasekaran is on Audit and Risk Oversight Committees; company thanks them for contributions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215701,"accession_number":"0000721371-24-000054","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-08-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q4 revenue +12% to $59.9B, non-GAAP EPS $1.84 (+29%); raises FY25 guidance to $7.55-$7.70","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $59.9B (+12% YoY); GAAP EPS $0.96, non-GAAP EPS $1.84 (+29%).","FY2024 revenue $226.8B (+11%), non-GAAP EPS $7.53 (+29%); operating cash flow record $3.8B.","FY2025 non-GAAP EPS guidance raised to $7.55-$7.70 from at least $7.50.","Pharmaceutical & Specialty Solutions segment profit +8% to $482M; GMPD profit $47M vs $7M YoY.","GMPD segment profit improved $40M to $47M driven by net inflationary mitigation initiatives."],"consensus_eps_estimate":null,"consensus_eps_actual":3.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":226827000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235101,"accession_number":"0000721371-24-000036","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Cardinal Health Q3 non-GAAP EPS $2.08 (+20% YoY); raises FY24 EPS guidance to $7.30-$7.40","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $54.9B (+9% YoY); GAAP diluted EPS $1.05; non-GAAP diluted EPS $2.08 (+20%).","Pharma & Specialty Solutions segment profit $580M (+4%); Global Medical Products segment profit $20M vs -$46M a year ago.","FY2024 non-GAAP EPS guidance raised to $7.30-$7.40 (from $7.20-$7.35); non-GAAP effective tax rate guidance lowered to 22%-23%.","Preliminary FY2025 non-GAAP EPS guidance at least $7.50; Pharma segment profit growth at least 1%; GMPD segment profit ~$175M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":167119000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235100,"accession_number":"0000721371-24-000030","cik":721371,"company_name":"CARDINAL HEALTH INC","ticker":"CAH","form_type":"8-K","filed_at":"2024-04-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Cardinal Health recasts segment results under new structure for FY2022-H1 FY2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New segments: Pharmaceutical & Specialty Solutions and Global Medical Products & Distribution; three smaller ops reported as Other.","Recast unaudited quarterly data for FY2022, FY2023, and H1 FY2024; no change to consolidated revenue or net income.","Pharm & Spec Solutions segment profit grew 13% in FY2023 to $1,862M; H1 FY2024 profit $961M.","Global Medical Products & Distribution segment losses: FY2022 loss $49M, FY2023 loss $162M, H1 FY2024 loss $2M.","Total segment revenue grew 13% in FY2023 to $205.1B; H1 FY2024 up 11% to $112.2B."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":46803697187.17333,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}